MMP9 and amyotrophic lateral sclerosis: Among genes previously shown to be elevated in “high inflammation” ALS patients, there was indeed a significant trend towards higher expression in our myeloid patient group (e.g., CD14, RXRA, MMP9; P = 0.015; Fig. 7g, h).